Google
XOMA 株価分析 — Xoma Royalty Corporation (Healthcare >> Biotechnology)
XOMA に関するよくある質問
XOMAのPER（株価収益率）は？
Xoma Royalty Corporation（XOMA）は現在PER 22.54倍で取引されています。
XOMAのROE（自己資本利益率）は？
Xoma Royalty CorporationのROEは27.91%です。
XOMAの配当利回りは？
Xoma Royalty Corporationの配当利回りは0.00%です。
XOMAの品質スコア（Quality Score）は？
当社のAIはXOMAの総合財務品質を100点中54点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
XOMAは今が買い時ですか？
当社AIのタイミングスコアは100点中87点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
XOMAはどのセクターに属しますか？
Xoma Royalty CorporationはHealthcare >> Biotechnologyセクターに分類されます（NASDAQ市場）
XOMA AI Analysis Summary
Our AI summary for XOMA: Xoma Royalty Corporation (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 22.54, ROE of 27.91%, a dividend yield of 0.00%. Its financial Quality Score stands at 54/100 — mid-range fundamentals relative to the market. The AI Timing Score is 87/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 40.17
Price
-4.05
(-9.16%)
Day Change
|
|
|---|
XOMA, ファンダメンタルスコアはnot quite good ( ファンダメンタル = 54) but テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEの伸びが低い
平均ROEが低い
ROAがROEに比べて低い
ROAの伸びが低い
NPMの伸びが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not good , financial health is not good , and ability to make profit is ok , ...
| Deepscope 分析 |
|
48% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | N/A |
| Magic Formula Rank by ROA |
886
|
| Magic Formula Rank by ROE |
886
|
| Magic Formula Rank by ROIC |
913
|
| Price | 40.17 |
| PBV / Sector |
6.29 / 44,022.72
|
| Earning Per Share | 1.78 |
| PE / Sector |
22.54 / 19.17
|
| PEG or PE/Growth / Sector |
-0.38 / 1.24
|
| Average 1M Daily Value |
15.54 M
GREAT
|
| Average 1W Daily Value |
42.31 M
GREAT
|
| Timing Factors |
|
42% |
| Financial Health |
|
45% |
| ポイントになる統計 |
|
64% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-08-05 08:01:06 |
| Symbol | XOMA |
| Name | XOMA ROYALTY CORPORATION |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 17.68 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 710.16 / 9,586.08 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 2200 Powell Street, EmeryVille, CA, United States, 94608
Phone: 510 204 7200
Website: https://www.xoma.com
Sector: Healthcare >> Biotechnology
Description: XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States, Switzerland, the Asia Pacific, and Australia. It has a portfolio of economic rights to future potential milestone and royalty payments associated with commercial products and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to sponsors or developers; and acquires milestone and royalty revenue streams on late-stage clinical assets and commercial assets. It has a portfolio with various assets. The company was formerly known as XOMA Corporation and changed its name to XOMA Royalty Corporation in July 2024. XOMA Royalty Corporation was incorporated in 1981 and is headquartered in Emeryville, California. As of July 14, 2026, XOMA Royalty Corporation operates as a subsidiary of Ligand Pharmaceuticals Incorporated.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
